S&P 500 concentration risk is surging—top 10 now 41%. See a quant-optimized 15-stock barbell from Strong Buy picks for better ...

Experimental - This project is still in development, and not ready for the prime time. A minimal, secure Python interpreter written in Rust for use by AI. Monty avoids the cost, latency, complexity ...

The stock market opened mixed on Thursday as investors were left underwhelmed by Nvidia’s (NVDA) fourth-quarter results and guidance. Nvidia was down 2% after the semiconductor giant reported fiscal ...

Stock index futures rose on Wednesday as investors geared up for Nvidia’s ( NVDA) fourth-quarter results slated to be out after the market close.

Stocks fell on Thursday, leaving the S&P 500 near the flat line for the year, as investors shifted away from financials and monitored simmering tensions between the U.S. and Iran. The Dow Jones ...

Apple's correlation to the Nasdaq 100 Index has declined, making it an appealing alternative to the AI-fueled volatility in the stock market. Apple's lack of participation in the AI arms race and its ...

The Business Services group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Agora, Inc. Sponsored ADR (API) is a stock that can ...

(RTTNews) - Stocks have seen considerable volatility over the course of the trading day on Friday, with the major averages swinging wildly back and forth across the unchanged line following the steep ...

Stocks dropped sharply Thursday as AI concerns came to the surface once again. The Nasdaq composite led major benchmarks lower with a loss of 2%. The Dow industrials retreated below 50000, down 669 ...

The S&P 500 closed barely above the flatline on Friday as a key consumer inflation report that came in slightly lighter than expected failed to spark a substantial rally. The broad market index added ...

BridgeBio Pharma Inc. (NASDAQ:BBIO) stock is surging on Thursday and nearing the upper end of its 52-week range of $28.33-$84.94, according to Benzinga Pro data. The biopharmaceutical company focused ...